Ausgabe 2/2017
Inhalt (33 Artikel)
Meta-analysis of tumour burden in pre-operative axillary ultrasound positive and negative breast cancer patients
Muneer Ahmed, F. Jozsa, R. Baker, I. T. Rubio, J. Benson, M. Douek
Erratum to: Meta-analysis of tumour burden in pre-operative axillary ultrasound positive and negative breast cancer patients
Muneer Ahmed, F. Jozsa, R. Baker, I. T. Rubio, J. Benson, M. Douek
Clinical and pathological characterization of HER2 mutations in human breast cancer: a systematic review of the literature
Fausto Petrelli, Gianluca Tomasello, Sandro Barni, Veronica Lonati, Rodolfo Passalacqua, Michele Ghidini
Breast cancer in Africa: prevalence, treatment options, herbal medicines, and socioeconomic determinants
Kiven Erique Lukong, Yetunde Ogunbolude, Jean Paul Kamdem
Does obesity modify the relationship between physical activity and breast cancer risk?
S. E. Neil-Sztramko, T. Boyle, E. Milosevic, S. F. Nugent, C. C. Gotay, K. L. Campbell
Amplification and overexpression of PSCA at 8q24 in invasive micropapillary carcinoma of breast
Fanfan Meng, Bingbing Liu, Gan Xie, Yawen Song, Xia Zheng, Xiaolong Qian, Shuai Li, Hongqin Jia, Xinmin Zhang, Lanjing Zhang, Yi-ling Yang, Li Fu
Therapeutic blockade of Foxp3 in experimental breast cancer models
Mariela A. Moreno Ayala, María Florencia Gottardo, Mercedes Imsen, Antonela S. Asad, Elisa Bal de Kier Joffé, Noelia Casares, Juan José Lasarte, Adriana Seilicovich, Marianela Candolfi
Riluzole synergizes with paclitaxel to inhibit cell growth and induce apoptosis in triple-negative breast cancer
Cecilia L. Speyer, Miriam A. Bukhsh, Waris S. Jafry, Rachael E. Sexton, Sudeshna Bandyopadhyay, David H. Gorski
Metalloprotease-dependent activation of EGFR modulates CD44+/CD24− populations in triple negative breast cancer cells through the MEK/ERK pathway
Randi Wise, Anna Zolkiewska
The prognostic value of the tumour-stroma ratio in primary operable invasive cancer of the breast: a validation study
Toni Roeke, Marcelo Sobral-Leite, Tim J. A. Dekker, Jelle Wesseling, Vincent T. H. B. M. Smit, Rob A. E. M. Tollenaar, Marjanka K. Schmidt, Wilma E. Mesker
HER2 intratumoral heterogeneity is independently associated with incomplete response to anti-HER2 neoadjuvant chemotherapy in HER2-positive breast carcinoma
Yanjun Hou, Hiroaki Nitta, Lai Wei, Peter M. Banks, Bryce Portier, Anil V. Parwani, Zaibo Li
Cross-cultural comparison of breast cancer patients’ Quality of Life in the Netherlands and Japan
M. J. Fischer, K. Inoue, A. Matsuda, J. R. Kroep, S. Nagai, K. Tozuka, M. Momiyama, N. I. Weijl, D. Langemeijer-Bosman, S. R. S. Ramai, J. W. R. Nortier, H. Putter, K. Yamaoka, K. Kubota, K. Kobayashi, A. A. Kaptein
Outcome following sentinel lymph node biopsy-guided decisions in breast cancer patients with conversion from positive to negative axillary lymph nodes after neoadjuvant chemotherapy
Young-Joon Kang, Wonshik Han, Soojin Park, Ji Young You, Ha Woo Yi, Sungmin Park, Sanggeun Nam, Joo Heung Kim, Keong Won Yun, Hee Jeong Kim, Sei Hyun Ahn, Seho Park, Jeong Eon Lee, Eun Sook Lee, Dong-Young Noh, Jong Won Lee
Prognostic and predictive importance of the estrogen receptor coactivator AIB1 in a randomized trial comparing adjuvant letrozole and tamoxifen therapy in postmenopausal breast cancer: the Danish cohort of BIG 1-98
S. Alkner, M.-B. Jensen, B. B. Rasmussen, P.-O. Bendahl, M. Fernö, L. Rydén, H. Mouridsen
Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial
Qamar J. Khan, Bruce F. Kimler, Pavan S. Reddy, Priyanka Sharma, Jennifer R. Klemp, Jennifer L. Nydegger, Hung-Wen Yeh, Carol J. Fabian
Clinical implementation of synthesized mammography with digital breast tomosynthesis in a routine clinical practice
Phoebe E. Freer, Joanna Riegert, Laura Eisenmenger, Dominik Ose, Nicole Winkler, Matthew A. Stein, Gregory J. Stoddard, Rachel Hess
Impact of pathologic diagnosis of internal mammary lymph node metastasis in clinical N2b and N3b breast cancer patients
Ji Hyeon Joo, Su Ssan Kim, Seung-Do Ahn, Eun Kyung Choi, Jin Hong Jung, Yuri Jeong, Sei Hyun Ahn, Byung Ho Son, Jong Won Lee, Hee Jung Kim, Beom Seok Go, Hak Hee Kim, Joo Hee Cha, Hee Jung Shin, Eun Young Chae
Long-term peripheral neuropathy symptoms in breast cancer survivors
Moaath Mustafa Ali, Machelle Moeller, Lisa Rybicki, Halle C. F. Moore
IPET study: an FLT-PET window study to assess the activity of the steroid sulfatase inhibitor irosustat in early breast cancer
Carlo Palmieri, Richard Szydlo, Marie Miller, Laura Barker, Neva H. Patel, Hironobu Sasano, Tara Barwick, Henry Tam, Dimitri Hadjiminas, Jasmin Lee, Abeer Shaaban, Hanna Nicholas, R. Charles Coombes, Laura M. Kenny
Vascular function in breast cancer survivors on aromatase inhibitors: a pilot study
Anne Blaes, Heather Beckwith, Natalia Florea, Robert Hebbel, Anna Solovey, David Potter, Douglas Yee, Rachel Vogel, Russell Luepker, Daniel Duprez
Association between survival time with metastatic breast cancer and aggressive end-of-life care
Melissa K. Accordino, Jason D. Wright, Sowmya Vasan, Alfred I. Neugut, Tal Gross, Grace C. Hillyer, Dawn L. Hershman
FOXA1 hypermethylation: link between parity and ER-negative breast cancer in African American women?
Allyson C. Espinal, Matthew F. Buas, Dan Wang, David Ting-Yuan Cheng, Lara Sucheston-Campbell, Qiang Hu, Li Yan, Rochelle Payne-Ondracek, Eduardo Cortes, Li Tang, Zhihong Gong, Gary Zirpoli, Thaer Khoury, Song Yao, Angela Omilian, Kitaw Demissie, Elisa V. Bandera, Song Liu, Christine B. Ambrosone, Michael J. Higgins
Relationship between mammographic calcifications and the clinicopathologic characteristics of breast cancer in Western China: a retrospective multi-center study of 7317 female patients
Ke Zheng, Jin-Xiang Tan, Fan Li, Yu-Xian Wei, Xue-Dong Yin, Xin-Liang Su, Hong-Yuan Li, Qi-Lun Liu, Bin-Lin Ma, Jiang-Hua Ou, Hui Li, Sui-Sheng Yang, Ai-Mei Jiang, Qing Ni, Jian-Lun Liu, Jin-Ping Liu, Hong Zheng, Zhang-Jun Song, Ling Wang, Jian-Jun He, Tian-Ning Zou, Jun Jiang, Guo-Sheng Ren
Trends in adjuvant therapies after breast-conserving surgery for hormone receptor-positive ductal carcinoma in situ: findings from the National Cancer Database, 2004–2013
Yasuaki Sagara, Rachel A. Freedman, Stephanie M. Wong, Fatih Aydogan, Anvy Nguyen, William T. Barry, Mehra Golshan
Tamoxifen therapy benefit for patients with 70-gene signature high and low risk
Laura J. van ‘t Veer, Christina Yau, Nancy Y. Yu, Christopher C. Benz, Bo Nordenskjöld, Tommy Fornander, Olle Stål, Laura J. Esserman, Linda Sofie Lindström
Joint relative risks for estrogen receptor-positive breast cancer from a clinical model, polygenic risk score, and sex hormones
Yiwey Shieh, Donglei Hu, Lin Ma, Scott Huntsman, Charlotte C. Gard, Jessica W. T. Leung, Jeffrey A. Tice, Elad Ziv, Karla Kerlikowske, Steven R. Cummings
Assessment of Ki67 expression for breast cancer subtype classification and prognosis in the Nurses’ Health Study
Megan A. Healey, Kelly A. Hirko, Andrew H. Beck, Laura C. Collins, Stuart J. Schnitt, A. Heather Eliassen, Michelle D. Holmes, Rulla M. Tamimi, Aditi Hazra
Detection of multicentric and contralateral breast cancers on MRI based on primary cancer biomarker status: will this change surgical or medical management?
Arti R. Jonna, Kenny Q. Sam, Lilian O. Ebuoma, Emily L. Sedgwick, Tao Wang, Ana P. Benveniste
Early onset breast cancer: differences in risk factors, tumor phenotype, and genotype between North African and South European women
Carole Corsini, Sarra Henouda, Dalel Ben Nejima, Héléna Bertet, Alain Toledano, Hamouda Boussen, Faouzi Habib, Asma Mouhout, Ahmed Gaballah, Hesham El Ghazaly, Céline Bourgier, Isabelle Coupier, Virginie Galibert, Karen Baudry, Paul Vilquin, Louise Biquard, Jean-Marc Rey, Yazid Belkacemi, Paul Ihout, David Khayat, Marie-Christine Picot, Assia Bensalem, Pascal Pujol
NanoString-based breast cancer risk prediction for women with sclerosing adenosis
Stacey J. Winham, Christine Mehner, Ethan P. Heinzen, Brendan T. Broderick, Melody Stallings-Mann, Aziza Nassar, Robert A. Vierkant, Tanya L. Hoskin, Ryan D. Frank, Chen Wang, Lori A. Denison, Celine M. Vachon, Marlene H. Frost, Lynn C. Hartmann, E. Aubrey Thompson, Mark E. Sherman, Daniel W. Visscher, Amy C. Degnim, Derek C. Radisky
Attitudes of female staff and students from two United Kingdom Medical Schools towards donating normal healthy breast tissue and blood samples for biomedical research
Harriet Wilson, Valerie Speirs